Martijn Cox
Founder at Xeltis AG
Martijn Cox active positions
Companies | Position | Start | End |
---|---|---|---|
Xeltis AG
Xeltis AG Medical SpecialtiesHealth Technology Xeltis AG develops medical devices to transform standards of care in heart valve replacement and vascular surgery. It develops fully bio absorbable synthetic heart valves and vascular grafts intended to enable for the first time the spontaneous growth of natural, healthy valves and vessels. Its medical device platform comprises bioabsorbable heart valves and blood vessels, designed to enable Endogenous Tissue Restoration (ETR), the natural restoration of the complex body part they replace upon implantation. The company was founded by Martijn Cox, Laurent Grandidier and Simon P. Hoerstrup in 2006 and is headquartered in Zurich, Switzerland. | Chief Tech/Sci/R&D Officer | 31/12/2005 | - |
Founder | 31/12/2005 | - | |
Xeltis BV
Xeltis BV Packaged SoftwareTechnology Services Xeltis BV develops self-growing heart valves out of patients tissue. The company was headquartered in Glasgow, the United Kingdom. The company was founded on November 20, 2007 by Mirjam Rubbens and Martijn Cox and is headquartered in Eindhoven, the Netherlands. | Founder | 19/11/2007 | - |
Career history of Martijn Cox
Training of Martijn Cox
TiasNimbas Business School BV | Doctorate Degree |
Statistics
International
Netherlands | 3 |
Switzerland | 2 |
Operational
Founder | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Doctorate Degree | 1 |
Sectoral
Consumer Services | 2 |
Health Technology | 2 |
Technology Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Xeltis AG
Xeltis AG Medical SpecialtiesHealth Technology Xeltis AG develops medical devices to transform standards of care in heart valve replacement and vascular surgery. It develops fully bio absorbable synthetic heart valves and vascular grafts intended to enable for the first time the spontaneous growth of natural, healthy valves and vessels. Its medical device platform comprises bioabsorbable heart valves and blood vessels, designed to enable Endogenous Tissue Restoration (ETR), the natural restoration of the complex body part they replace upon implantation. The company was founded by Martijn Cox, Laurent Grandidier and Simon P. Hoerstrup in 2006 and is headquartered in Zurich, Switzerland. | Health Technology |
Xeltis BV
Xeltis BV Packaged SoftwareTechnology Services Xeltis BV develops self-growing heart valves out of patients tissue. The company was headquartered in Glasgow, the United Kingdom. The company was founded on November 20, 2007 by Mirjam Rubbens and Martijn Cox and is headquartered in Eindhoven, the Netherlands. | Technology Services |
- Stock Market
- Insiders
- Martijn Cox
- Experience